Lifespan extension by reverse fasting
Lifespan extension by reverse fasting
批准号:
10575272
负责人:
Michael Petrascheck
金额:
$27.15万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-03-01 至 2024-12-31
关键词:
AgingAnimal FeedAnimalsCD2 AntigensCaenorhabditis elegansCandidate Disease GeneCyclic AMPDietDoseEatingEnergy IntakeEnergy MetabolismEnergy SupplyEnergy consumptionEquilibriumFastingFatigueFutureG-Protein-Coupled ReceptorsGene ExpressionGenerationsGenesHealthHyperphagiaInsulinIntakeInterventionLinkLongevityMeasuresMediatingMetabolicMitochondriaModelingPathway interactionsPhenotypePredispositionRNA InterferenceRespirationSerotoninSignal TransductionStarvationTestingTimeempowermentexperimental studyfeedingfollow-upknock-downmutantpreventreduced food intakeresponseserotonin receptortrigger point
中文摘要
项目摘要
在我们题为”通过反向禁食延长寿命”的申请中,我们提出了一种新的模型,
新陈代谢和衰老。在这个模型中,长寿机制是由能量不足引发的,
摄入量不能提供足够的能量来匹配动物的能量消耗(经典禁食)。这
模型进一步表明,增加能量消耗,同时保持食物摄入量不变(反向禁食)
也会导致能量不足从而延长寿命
在这个应用程序中,我们使用C。elegans来测试这些想法。我们发现G蛋白偶联受体SER-7
控制能量消耗。5-羟色胺对SER-7的激活剂量依赖性地增加能量需求,
线粒体呼吸和随后的食物摄入。在野生型N2动物中,
外源性5-羟色胺始终与食物摄入量的等量增加相匹配,
产生能量赤字。测试八种不同的长寿突变体,我们发现,
能量消耗和食物摄入都受到严格限制,但其中一个,揭示了存在一个
长寿突变体的一般节能机制。例如,daf-2(e1370)突变体具有大约一半的
野生型动物的呼吸和食物摄入率,以及它们响应于血清素的食物摄入,
严重短打。然而,我们鉴定了一个daf-2突变体,它具有几乎野生型的呼吸和食物摄取
profile.只有对高浓度外源性5-羟色胺的反应稍微迟钝,这表明
在daf-2(e1370)中观察到的拟议节能机制未激活。我们发现缺乏能量-
DAF-2突变体中的节省机制提高了代谢设定点,
被触发了其结果是,当动物已经吃了两倍的食物时,
就像野生型一样。这个daf-2突变体是反向禁食假说的第一个证实。这表明,
是可能产生的动物,活得长,吃得过多,只要能量消耗高于
能量摄入本申请旨在确定禁食/饥饿诱导的节能机制,
表明它的失活将使许多长寿突变体吃得过多而活得更长。
英文摘要
Project Summary
In our application entitled" Lifespan extension by reverse fasting," we propose a new model connecting energy
metabolism and aging. In this model, longevity mechanisms are triggered by an energy deficit in which the food
intake does not provide enough energy to match the animal's energy expenditure (classical fasting). This
model further suggests that increasing energy expenditure while keeping food intake constant (reverse fasting)
should also generate an energy deficit that triggers longevity.
In this application, we use C. elegans to test these ideas. We find that the G protein-coupled receptor SER-7
controls energy expenditure. Activation of SER-7 by serotonin dose-dependently increases energy demand,
mitochondrial respiration, and subsequently food intake. In wild-type N2 animals increasing energy demand by
exogenous serotonin is consistently matched by an equivalent increase in food intake, preventing the
generation of an energy deficit. Testing eight different longevity mutants, we find that the ability to upregulate
energy expenditure and food intake is severely restricted in all but one of them, revealing the existence of a
general energy-saving mechanism in longevity mutants. For example, daf-2(e1370) mutants have roughly half
the respiration and food intake rate of wild-type animals, and their food intake in response to serotonin is
severely bunted. However, we identified a daf-2 mutant with an almost wild-type respiration and food intake
profile. Only the response to exogenous serotonin at high concentrations is slightly blunted, suggesting the
proposed energy-saving mechanism observed in daf-2(e1370) is not active. We find that the lack of an energy-
saving mechanism in that daf-2 mutant elevates the metabolic set point at which the dauer pathway is
triggered. The result is an animal that activates the dauer pathway at a point when it already eats twice as
much as wild type. This daf-2 mutant is the first confirmation of the reverse fasting hypothesis. It shows that it
is possible to generate animals that live long and overeat, as long as the energy expenditure is higher than the
energy intake. This application aims to identify the fasting/starvation-induced energy-saving mechanism and to
show that its inactivation will enable many longevity mutants to overeat and live long.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lowering Mitochondrial ATP Synthase Activity Slows Aging and Alzheimer's Disease
-
批准号:10437597
-
项目类别:
-
资助金额:$89.83万
-
财政年份:2020
-
负责人:Michael Petrascheck
-
依托单位:
Lowering Mitochondrial ATP Synthase Activity Slows Aging and Alzheimer's Disease
-
批准号:10653496
-
项目类别:
-
资助金额:$33.63万
-
财政年份:2020
-
负责人:Michael Petrascheck
-
依托单位:
Lowering Mitochondrial ATP Synthase Activity Slows Aging and Alzheimer's Disease
-
批准号:10618893
-
项目类别:
-
资助金额:$91.1万
-
财政年份:2020
-
负责人:Michael Petrascheck
-
依托单位:
Mechanisms of mRNA translation that modulate protein aggregation
-
批准号:9585954
-
项目类别:
-
资助金额:$29.03万
-
财政年份:2018
-
负责人:Michael Petrascheck
-
依托单位:
Modulation of Sensory Perception to Treat Age Related Disease
-
批准号:8145486
-
项目类别:
-
资助金额:$284.25万
-
财政年份:2011
-
负责人:Michael Petrascheck
-
依托单位:
海外基金